Recently, phosphoglucose isomerase with a lysyl aminopeptidase (PGI-LysAP) activity was identified in Vibrio vulnificus. In this paper, we demonstrate the proteolytic cleavage of human-derived peptides by PGILysAP of V. vulnificus using three approaches: (i) a quantitative fluorescent ninhydrin assay for free lysine, (ii) matrix-assisted laser desorption ionization-two-stage time of flight mass spectrometry (MALDI-TOF-TOF), and (iii) Tricine gel electrophoresis. PGI-LysAP hydrolyzed bradykinin, Lys-bradykinin, Lys-(des-Arg 9 )-bradykinin, neurokinin A, Met-Lys-bradykinin, histatin 8, and a myosin light chain fragment. We detected the proteolytic release of free L-lysine from peptide digests using a rapid, simple, sensitive, and quantitative fluorescent ninhydrin assay, and results were confirmed by MALDI-TOF-TOF. The use of the fluorescent ninhydrin assay to quantitatively detect free lysine hydrolyzed from peptides is the first application of its kind and serves as a paradigm for future studies. The visualization of peptide hydrolysis was accomplished by Tricine gel electrophoresis. Proteolytic processing of kinins alters their affinities toward specific cellular receptors and initiates signal transduction mechanisms responsible for inflammation, vasodilation, and enhanced vascular permeability. By applying novel approaches to determine the proteolytic potential of bacterial enzymes, we demonstrate that PGI-LysAP has broad exopeptidase activity which may enhance V. vulnificus invasiveness by altering peptides involved in signal transduction pathways.Vibrio vulnificus is a naturally occurring marine bacterium indigenous to temperate and tropical estuarine environments. It has two routes of transmission: wound infections and the ingestion of contaminated seafood, especially raw oysters. During summer months, nearly 100% of the oysters harvested from the Gulf of Mexico contain V. vulnificus (9). Liver cirrhosis, hemochromatosis, diabetes, kidney disease, and immune disorders predispose individuals to V. vulnificus infection via the food-borne route (4, 24); however, even seemingly healthy individuals are susceptible to V. vulnificus through wound infections (24). Symptoms include fever, chills, hypotension, and the development of secondary bullous skin lesions. Septicemia is common, and death can occur within 24 h after contact with the pathogen (8, 24). Mortality rates for V. vulnificus infections are approximately 60% in the United States (15) but are somewhat higher in Asian countries (14,25).Over the past two decades, numerous virulence factors have been identified in V. vulnificus based on cell culture and animal models; however, the validity of these models in assessing virulence has come into question (7). A case in point involves V. vulnificus protease, a well-characterized metalloprotease (23). In the mouse model, injection of this protease causes skin necrosis; however, knockout of the gene in V. vulnificus does not attenuate the symptoms in Vibrio-infected laboratory animals (34).Recently, we isolated a...